AU566110B2 - Controlled release osmotic device - Google Patents

Controlled release osmotic device

Info

Publication number
AU566110B2
AU566110B2 AU22511/83A AU2251183A AU566110B2 AU 566110 B2 AU566110 B2 AU 566110B2 AU 22511/83 A AU22511/83 A AU 22511/83A AU 2251183 A AU2251183 A AU 2251183A AU 566110 B2 AU566110 B2 AU 566110B2
Authority
AU
Australia
Prior art keywords
controlled release
osmotic device
release osmotic
controlled
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU22511/83A
Other languages
English (en)
Other versions
AU2251183A (en
Inventor
Brian Barclay
Joseph C. Deters
Felix Theeuwes
Patrick S.L. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU566110(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of AU2251183A publication Critical patent/AU2251183A/en
Application granted granted Critical
Publication of AU566110B2 publication Critical patent/AU566110B2/en
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
AU22511/83A 1983-05-11 1983-12-19 Controlled release osmotic device Expired AU566110B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11
US493760 1983-05-11

Publications (2)

Publication Number Publication Date
AU2251183A AU2251183A (en) 1984-11-15
AU566110B2 true AU566110B2 (en) 1987-10-08

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22511/83A Expired AU566110B2 (en) 1983-05-11 1983-12-19 Controlled release osmotic device

Country Status (20)

Country Link
JP (1) JPS6041609A (fr)
AT (1) AT397180B (fr)
AU (1) AU566110B2 (fr)
BE (1) BE898819A (fr)
CA (1) CA1222950A (fr)
CH (1) CH669329A5 (fr)
DE (1) DE3417113A1 (fr)
DK (1) DK163910C (fr)
ES (1) ES532018A0 (fr)
FR (1) FR2545721B1 (fr)
GB (1) GB2140687B (fr)
IE (1) IE56515B1 (fr)
IL (1) IL71727A (fr)
IT (1) IT1178911B (fr)
MX (1) MX163518B (fr)
NL (1) NL192250C (fr)
NO (1) NO170834C (fr)
NZ (1) NZ206600A (fr)
SE (1) SE455918B (fr)
ZA (1) ZA842422B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU615104B2 (en) * 1988-08-30 1991-09-19 Pfizer Inc. The use of asymmetric membranes in delivery devices

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (fr) * 1987-11-25 1992-05-20 American Cyanamid Company Système de délivrance retardée (contrôlée) de dihydropyridine antagonistes de calcium substitués
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
ES2053339T3 (es) * 1990-09-28 1994-07-16 Pfizer Dispositivo dispensador conteniendo un medio hidrofobo.
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ATE200221T1 (de) * 1993-02-23 2001-04-15 Wolfgang Dr Werner Die verwendung eines calciumpräparates in einem medikament zur behandlung von an hypocalcämie leidenden milchkühen
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
MXPA03003895A (es) * 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
PL1663175T3 (pl) * 2003-09-19 2012-09-28 Sun Pharma Advanced Res Co Ltd Doustny system podawania leku
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (fr) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention et traitement de troubles thromboemboliques
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
PL1934208T3 (pl) 2005-10-04 2011-09-30 Bayer Ip Gmbh Nowa polimorficzna postać 5-chloro-N-({ (5S)-2-okso-3-[4-( 3-okso-4-morfolinylo)-fenylo]-1,3-oksazolidyn-5-ylo}-metylo)-2-tiofenokarboksamidu
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US8956654B2 (en) * 2009-06-02 2015-02-17 Dow Global Technologies Llc Sustained release dosage form
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
MX2014013320A (es) 2012-05-07 2015-08-10 Bayer Pharma AG Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo.
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
MX2021000904A (es) 2018-07-24 2021-03-31 Bayer Ag Forma de dosificacion farmaceutica administrable por via oral con liberacion modificada.
EP3826619A1 (fr) 2018-07-24 2021-06-02 Bayer Aktiengesellschaft Formes galéniques pharmaceutiques à libération modifiée à administrer par voie orale
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU615104B2 (en) * 1988-08-30 1991-09-19 Pfizer Inc. The use of asymmetric membranes in delivery devices

Also Published As

Publication number Publication date
JPH0575725B2 (fr) 1993-10-21
JPS6041609A (ja) 1985-03-05
BE898819A (fr) 1984-05-30
FR2545721A1 (fr) 1984-11-16
IT8467283A1 (it) 1985-09-23
SE8402512D0 (sv) 1984-05-09
NO170834B (no) 1992-09-07
DK163910B (da) 1992-04-21
NL8401470A (nl) 1984-12-03
CH669329A5 (fr) 1989-03-15
AU2251183A (en) 1984-11-15
IL71727A (en) 1989-01-31
IT8467283A0 (it) 1984-03-23
AT397180B (de) 1994-02-25
NL192250B (nl) 1996-12-02
NZ206600A (en) 1987-01-23
FR2545721B1 (fr) 1987-11-06
DK99784A (da) 1984-11-12
CA1222950A (fr) 1987-06-16
ATA88084A (de) 1993-07-15
GB8334189D0 (en) 1984-02-01
ES8503503A1 (es) 1985-03-01
DK163910C (da) 1992-09-14
GB2140687A (en) 1984-12-05
NL192250C (nl) 1997-04-03
NO840248L (no) 1984-11-12
ES532018A0 (es) 1985-03-01
IT1178911B (it) 1987-09-16
SE455918B (sv) 1988-08-22
DE3417113C2 (fr) 1989-02-02
ZA842422B (en) 1984-11-28
DK99784D0 (da) 1984-02-24
NO170834C (no) 1992-12-16
MX163518B (es) 1992-05-25
DE3417113A1 (de) 1984-11-15
GB2140687B (en) 1987-03-18
IE840010L (en) 1984-11-11
SE8402512L (sv) 1984-11-12
IE56515B1 (en) 1991-08-28
IL71727A0 (en) 1984-09-30

Similar Documents

Publication Publication Date Title
AU566110B2 (en) Controlled release osmotic device
AU558500B2 (en) Controlled slow release tablet
GB8418421D0 (en) Controlled release device
AU552080B2 (en) Controlled release naproxen tablets
AU563720B2 (en) Connecting device
AU2890184A (en) Safety device
AU1277083A (en) Prosthetic occlusive device
AU563884B2 (en) Secret-speech device
AU559356B2 (en) Port forming device
AU562845B2 (en) Clamping device
AU569545B2 (en) Locking device for wear-parts
AU565641B2 (en) Connecting device
AU2712184A (en) Clamping device
AU556090B2 (en) Controlled release formulations
AU2410784A (en) Signalling device
AU566714B2 (en) Gripping device
AU572843B2 (en) Clamping device
GB8405085D0 (en) Controlled release formulation
AU1277383A (en) Slow release pesticide
AU566689B2 (en) Holding magnet release device
AU555686B2 (en) Radiogoniometric device
AU2252183A (en) Grafting device
AU3555784A (en) Anchor device
AU2270883A (en) Weaving device
GB8314644D0 (en) Controlled release device

Legal Events

Date Code Title Description
NDB Extension of term for standard patent granted (sect.76)

Free format text: PRODUCT NAME: ADALAT OROS

Extension date: 20081219

MK14 Patent ceased section 143(a) (annual fees not paid) or expired